GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Medical Solutions Group PLC (LSE:AMS) » Definitions » 1-Year ROIIC %

Advanced Medical Solutions Group (LSE:AMS) 1-Year ROIIC % : -92.52% (As of Jun. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Advanced Medical Solutions Group 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Advanced Medical Solutions Group's 1-Year ROIIC % for the quarter that ended in Jun. 2024 was -92.52%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Advanced Medical Solutions Group's 1-Year ROIIC % or its related term are showing as below:

LSE:AMS's 1-Year ROIIC % is ranked worse than
80.91% of 833 companies
in the Medical Devices & Instruments industry
Industry Median: 1.87 vs LSE:AMS: -92.52

Advanced Medical Solutions Group 1-Year ROIIC % Historical Data

The historical data trend for Advanced Medical Solutions Group's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Medical Solutions Group 1-Year ROIIC % Chart

Advanced Medical Solutions Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
1-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.36 -38.67 -101.40 6.94 -20.53

Advanced Medical Solutions Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 250.34 6.94 -3.50 -20.53 -92.52

Competitive Comparison of Advanced Medical Solutions Group's 1-Year ROIIC %

For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Medical Solutions Group's 1-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Advanced Medical Solutions Group's 1-Year ROIIC % falls into.



Advanced Medical Solutions Group 1-Year ROIIC % Calculation

Advanced Medical Solutions Group's 1-Year ROIIC % for the quarter that ended in Jun. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( 9.1721 (Jun. 2024) - 17.9079 (Jun. 2023) )/( 210.183 (Jun. 2024) - 200.741 (Jun. 2023) )
=-8.7358/9.442
=-92.52%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Advanced Medical Solutions Group  (LSE:AMS) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Advanced Medical Solutions Group 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Advanced Medical Solutions Group's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Advanced Medical Solutions Group Business Description

Traded in Other Exchanges
Address
Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, GBR, CW7 3RT
UK-based Advanced Medical Solutions was founded in 1991 to design, develop, and manufacture advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The firm derives approximately 60% of total revenue from branded products, with nonbranded contributing 40%.